Aids in determining if Paxlovid (nirmatrelvir boosted with ritonavir) is appropriate therapy in an adult COVID-19 positive patient. Paxlovid is an oral antiviral treatment authorized for mild-to-moderate COVID-19 in patients at high risk for progression to severe COVID-19, including hospitalization or death. The tool evaluates eligibility based on FDA guidelines including age, weight, symptom duration, disease severity, kidney function, high-risk conditions, and potential contraindications. Proper patient selection is crucial as the medication must be started within 5 days of symptom onset and has significant drug interactions requiring careful evaluation. The assessment helps clinicians systematically determine appropriate candidates for this time-sensitive antiviral therapy.
Awaiting Clinical Input
Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.
The Indications for Paxlovid is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within infectious disease.
Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.
Paxlovid not recommended
Paxlovid contraindicated
Paxlovid indicated - standard dose
Paxlovid indicated - reduced dose
Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.
Open in Web AppClinical Decision Support (CDS) Notice & Legal Disclaimer
This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.